Loading
Life sciences · Interventional Study
ClinicalTrials.gov · October 6, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Interventional Study.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07706816). This is a study registration, not published results. Lead sponsor: Uppsala University. Recruitment status: RECRUITING. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 30 participants (ESTIMATED). Conditions: Cardiac Disease, Depression and Quality of Life, Cardiac Distress, Myocardial Infarction, Psychological Distress, Anxiety. Interventions: BEHAVIORAL: Remote-delivery Balance in Everyday Life (rBEL) Program for Myocardial Infarction Patients Younger Than 55 Years With Cardiac Distress. Primary outcome measures: Recruitment , Six weeks from when the invitation letter was sent out; Acceptability , Four weeks from the screening interview; Participant adherence , From start of intervention to 12 weeks later.; Retention , From the end of the intervention to two weeks later.; Adverse events , From intervention start to four weeks after intervention end.; Program credibility , Rating is done after first intervention session (first week of intervention). A two week submission period is allowed.; Program satisfaction , From the end of the intervention to two weeks later.. Brief summary: The goal of this feasibility study is to learn if the randomised controlled trial evaluating the Remote-delivery Balance in Everyday Life (rBEL) programme for adults younger than 55 years who have experienced a myocardial infarction (MI), is feasible. The objective is to examine the feasibility of the rBEL programme and the associated study procedures before a controlled evaluation of the programme. This is an uncontrolled, single-arm, pre-post treatment designed study. Participants of the target population will take part of the six session over 13 week programme. Feasibility will be evaluated against predefined feasibility criteria regarding study procedures and programme acceptability.